J-Lex

Stivarga tablets 40mg

Stivarga tablets 40mg (Regorafenib hydrate) from Bayer Pharmaceutical, YJ code 4291029F1028 (40mg 1 tablet), is a targeted therapy used to treat metastatic colorectal cancer, advanced gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More from this manufacturer